Tiger Global's tech-focused portfolio hits $26.59B with Meta, Microsoft, and Amazon leading. Discover new positions and ...

Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and ...

Healthcare has been a tough sector in 2025. It looks like Q2 could be the low point for healthcare earnings growth for this ...

Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward ...

Although as of this week the stock has declined by more than 4% since the start of the year, there's little reason to believe ...

BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

This was the stock's fifth consecutive day of gains.

TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...

Erste Group has downgraded Eli Lilly from a buy to a hold rating due to concerns about its earnings forecast. Despite 36.38% ...

Erin McCarthy wrote about emerging markets for The Wall Street Journal and Dow Jones Newswires, covering foreign exchange, fixed income and broader investment trends. She is also the creator and host ...

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...